⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3813203 | 0.84 | — | — | |
| SCHEMBL8888043 | 0.76 | — | — | |
| SCHEMBL5832051 | 0.73 | — | — | |
| SCHEMBL13366336 | 0.70 | SLC18A3 (0.38) | — | |
| SCHEMBL19302350 | 0.69 | — | — | |
| SCHEMBL14382099 | 0.69 | DRD2 (0.37) | — | |
| SCHEMBL9294037 | 0.68 | ESR2 (0.37) | — | |
| SCHEMBL2506554 | 0.68 | — | — | |
| SCHEMBL15416697 | 0.68 | — | — | |
| SCHEMBL12918305 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105111173-B | Statin fluorine-containing derivant and application thereof | 上海应用技术学院 | 2017-06-23 | — | — | CN | claimed |
| JP-6340593-A | — | — | None | — | — | JP | disclosed |
| US-12612611-B2 | Tetrahedral antibodies | BIOMOLECULAR HOLDINGS LLC (US) | 2026-04-28 | — | — | US | disclosed |
| US-12509502-B2 | Hybrid immunoglobulin containing nonpeptidyl linkage | BIOMOLECULAR HOLDINGS LLC (US) | 2025-12-30 | — | — | US | disclosed |
| US-12502368-B2 | Treatment and diagnosis of melanoma | THE ROCKEFELLER UNIVERSITY (US) | 2025-12-23 | — | — | US | disclosed |
| US-12473363-B2 | NK/monocyte engagers | BIOMOLECULAR HOLDINGS LLC | 2025-11-18 | — | — | US | disclosed |
| US-20250179183-A1 | NK/MONOCYTE ENGAGERS | BIOMOLECULAR HOLDINGS LLC (US) | 2025-06-05 | — | — | US | disclosed |
| US-20250092160-A1 | T CELL ENGAGERS | BIOMOLECULAR HOLDINGS LLC (US) | 2025-03-20 | — | — | US | disclosed |
| US-20250084169-A1 | NK/MONOCYTE ENGAGERS | BIOMOLECULAR HOLDINGS LLC (US) | 2025-03-13 | — | — | US | disclosed |
| EP-4463485-A2 | TETRAHEDRAL ANTIBODIES | Biomolecular Holdings LLC (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2011130476-A2 | POLYMER-BASED THERAPEUTIC AGENTS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2011-10-20 | — | — | WO | disclosed |
| WO-2010098886-A1 | POLYAMINE INHIBITORS FOR THE TREATMENT AND PREVENTION OF PARKINSON'S DISEASE | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2010-09-02 | — | — | WO | disclosed |
| US-20090286993-A1 | PROCESS FOR PRODUCING CYCLIC N-HYDROXY IMIDE COMPOUNDS | KAJIKAWA YASUTERU | 2009-11-19 | — | — | US | disclosed |
| US-7582774-B2 | Process for producing cyclic N-hydroxy imide compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-09-01 | — | — | US | disclosed |
| US-20070197798-A1 | Process for producing cyclic n-hydroxy imide compounds | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1757583-A1 | PROCESS FOR PRODUCING CYCLIC N-HYDROXYIMIDE COMPOUND | Daicel Chemical Industries, Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| US-7034095-B2 | Bicyclic conjugated diene polymer and bicyclic conjugated diene copolymer | NIPPON PETROCHEMICALS CO., LTD. (JP) | 2006-04-25 | — | — | US | disclosed |
| US-20060020094-A1 | Bicyclic conjugated diene polymer and bicyclic conjugated diene copolymer | NIPPON PETROCHEMICALS CO., LTD. (JP) | 2006-01-26 | — | — | US | disclosed |
| CN-1546481-A | Huivastatin, its synthesizing method and preparation with huivastatin as materials | 叶红平 | 2004-11-17 | — | — | CN | disclosed |
| JP-H06340593-A | TETRAHYDRONAPHTHALENE DERIVATIVE AND LAYER ELEMENT CONTAINING THE SAME | HOECHST AG | 1994-12-13 | — | — | JP | disclosed |